| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/2008 | EP1601669B1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
| 12/24/2008 | EP1599096B1 Hetero substitued sodium channel blockers |
| 12/24/2008 | EP1562568B1 Treatment of heaves |
| 12/24/2008 | EP1558242B1 Combination comprising docetaxel and a cdk inhibitor |
| 12/24/2008 | EP1554274B1 1-acyl-pyrrolidine derivatives for the treatment of viral infections |
| 12/24/2008 | EP1553952B1 Use of dihydroimidazolones for the treatment of epilepsy in dogs |
| 12/24/2008 | EP1549340B1 Biofunctional cpg or oligo-/polynucleotide and toxin or enterotoxin containing composition |
| 12/24/2008 | EP1545502A4 Keto cannabinoids with therapeutic indications |
| 12/24/2008 | EP1534508B1 Embossable and writable multilaminate backing construction |
| 12/24/2008 | EP1531819B1 USE OF I kappa B KINASE INHIBITORS FOR THE TREATMENT OF PAIN |
| 12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
| 12/24/2008 | EP1501503B1 Substantially pure solid form of the enol tautomer of 3-indolypyruvic acid for use in the treatment of central nervous system disturbances |
| 12/24/2008 | EP1461306B1 Quaternary ammonium compounds and their use as antimuscarinic agents |
| 12/24/2008 | EP1401418B1 Topical treatments using alkanolamines |
| 12/24/2008 | EP1390021B1 Delivery of compounds for the treatment of migraine through an inhalation route |
| 12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
| 12/24/2008 | EP1341786B1 Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain |
| 12/24/2008 | EP1218511B1 Antimicrobial compositions |
| 12/24/2008 | EP1181555B1 Cancer treatment with endothelin receptor antagonists |
| 12/24/2008 | EP1017399B1 Camptothecin analogs and methods of preparation thereof |
| 12/24/2008 | EP1003773B1 Ctl epitopes of epstein-barr virus |
| 12/24/2008 | EP0850047B1 Therapeutic lipidic vesicles: methods of use and compositions |
| 12/24/2008 | DE69922977C5 Neue Kristallmodifikation von Torasemid New crystal modification of torasemide |
| 12/24/2008 | DE20321698U1 Medikament zur Erhöhung der Bioverfügbarkeit von Alendronat oder einem anderen Bisphosphonat durch Verabreichen einer Vordosis eines Vitamin-D-Derivats Medicament for increasing the bioavailability of alendronate or another bisphosphonate by administration of a predose of a vitamin D-derivative |
| 12/24/2008 | DE112007000079T5 Neuartige Bis-Pyrrolo[2,1-c][1,4]benzodiazepin-anthrachinon Konjugate und ein Verfahren zu deren Herstellung Novel bis-pyrrolo [2,1-c] [1,4] benzodiazepine-anthraquinone conjugates and a method for their preparation |
| 12/24/2008 | DE102008017031A1 Kohlenwasserstoff Gemische und ihre Verwendung Hydrocarbon mixtures and their use |
| 12/24/2008 | DE102007029042A1 Pharmazeutische Zusammensetzung mit einem Trihydroxychromenone-Derivate A pharmaceutical composition comprising a Trihydroxychromenone derivatives |
| 12/24/2008 | DE102007028869A1 Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil A process for preparing a pharmaceutical comprising tadalafil |
| 12/24/2008 | DE102007028521A1 Indazolamidderivate Indazolamidderivate |
| 12/24/2008 | DE102007028515A1 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate 6- (pyrrolopyridinyl) -pyrimidinyl-2-amine derivatives |
| 12/24/2008 | DE102007028407A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028406A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028320A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028319A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 12/24/2008 | DE102007028318A1 Oxazolidinone zur Behandlung und Prophylaxe von Sepsis Oxazolidinones for the treatment and prophylaxis of sepsis |
| 12/24/2008 | DE102007028198A1 New alkyl-ketone compounds are histone deacetylase inhibitors, useful to treat e.g. cancer, hematologic or solid tumors, non-Hodgkins tumors, T-cell lymphoma, type I diabetes or Hashimoto's thyroiditis, and to modulate e.g. cell cycle |
| 12/24/2008 | CN201167623Y Insoles for treating beriberi |
| 12/24/2008 | CN101331262A Method for finishing textiles with care oils |
| 12/24/2008 | CN101331230A Methods and compositions for treating immune disorders |
| 12/24/2008 | CN101331229A Immunostimulatory oligoribonucleotides |
| 12/24/2008 | CN101331147A Method for preparing 4-demethyldaunorubicin |
| 12/24/2008 | CN101331146A Analogs of alpha galactosylceramide and uses thereof |
| 12/24/2008 | CN101331143A Hypophosphorous acid derivatives and their therapeutical applications |
| 12/24/2008 | CN101331139A New crystalline form of vinflunine ditartrate |
| 12/24/2008 | CN101331138A One pot synthesis of tetrazole derivatives of sirolimus |
| 12/24/2008 | CN101331137A Antitumour compounds |
| 12/24/2008 | CN101331135A Novel imidazopyrazines as cyclin dependent kinase inhibitors |
| 12/24/2008 | CN101331134A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/24/2008 | CN101331133A Sulphonamidoaniline derivatives being Janus kinases inhibitors |
| 12/24/2008 | CN101331132A [ (1H- indol- 5 -yl) -heteroaryloxy] - (1-aza-bicyclo [3.3.1] nonanes as cholinergic ligands of the n-AChR for the treatment of psychotic and neurodegenrative disorders |
| 12/24/2008 | CN101331131A Pyrrolo [2, 3-b] pyridine derivatives as h3 receptor modulators |
| 12/24/2008 | CN101331129A Dibenzonaphthyridine derivatives and methods of use thereof |
| 12/24/2008 | CN101331128A Novel forms of tiotropium bromide and processes for preparation thereof |
| 12/24/2008 | CN101331127A 5-aryl isoxazolines for controlling invertebrate pests |
| 12/24/2008 | CN101331126A Benzimidazole thiophene compounds as PLK modulators |
| 12/24/2008 | CN101331125A N-(5-membered aromatic ring)-amido anti-viral compounds |
| 12/24/2008 | CN101331124A Novel vanilloid receptor ligands and their use for producing medicaments |
| 12/24/2008 | CN101331123A Benzamide compounds useful as histone deacetylase inhibitors |
| 12/24/2008 | CN101331122A Salts of modulators of PPAR and methods of treating metabolic disorders |
| 12/24/2008 | CN101331120A Novel heterocycle compounds |
| 12/24/2008 | CN101331118A Pyrazoles useful in the treatment of inflammation |
| 12/24/2008 | CN101331117A 5-lipoxygenase-activating protein (FLAP) inhibitors |
| 12/24/2008 | CN101331116A N-(6-membered aromatic ring)-amido anti-viral compounds |
| 12/24/2008 | CN101331115A Derivatives for modulation of ion channels |
| 12/24/2008 | CN101330935A Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
| 12/24/2008 | CN101330920A Liquid medicine for internal use |
| 12/24/2008 | CN101330919A Pharmaceutical composition including (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrim idin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid |
| 12/24/2008 | CN101330918A Pyridopyrazine derivatives and use thereof as modulators of the signal transduction paths |
| 12/24/2008 | CN101330917A Fixed ratio drug combination treatments for solid tumors |
| 12/24/2008 | CN101330916A Substituted imidazoquinolines, imidazonaphthyridines, and imidazopyridines, compositions, and methods |
| 12/24/2008 | CN101330915A Pharmaceutical compositions containing Erythrine mulungu derivatives and processes for their production |
| 12/24/2008 | CN101330914A Control of intraocular pressure using ALK5 modulation agents |
| 12/24/2008 | CN101330913A Modified and pulsatile release pharmaceutical formulations of escitalopram |
| 12/24/2008 | CN101330912A Pharmaceutical composition of docetaxel, preparation method and purpose |
| 12/24/2008 | CN101330911A Hydroxy-oligocarboxylic esters: effects on nerve and use for cutaneous and mucocutaneous organs or sites |
| 12/24/2008 | CN101330910A Bisoprolol-containing adhesive patch |
| 12/24/2008 | CN101330909A Use of A3 adenosine receptor agonist in osteoarthritis treatment |
| 12/24/2008 | CN101330907A Solid oral pharmaceutical compositions for once daily dosing containing pregabalin, a matrix forming agent and a swelling agent |
| 12/24/2008 | CN101330906A HCV prodrug formulation |
| 12/24/2008 | CN101330903A Abuse resistant transmucosal drug delivery device |
| 12/24/2008 | CN101330839A Extract liquid containing -cryptoxanthin ingredient, and food or beverage and soap or cosmetic each containing the extract liquid |
| 12/24/2008 | CN101330838A Method for preventing diseases in infants delivered via caesarean section |
| 12/24/2008 | CN101330837A Method for treating and/or preventing infections in infants delivered via caesarean section |
| 12/24/2008 | CN101330835A Nutritional formulations containing octenyl succinate anahydride-modified tapioca starch |
| 12/24/2008 | CN101328476A Nucleic acid molecule NRN1SR32 and use thereof in anti-cancer medicine preparation |
| 12/24/2008 | CN101328475A Nucleic acid molecule NRN1SR11 and use thereof in anti-cancer medicine preparation |
| 12/24/2008 | CN101328472A Epidermal growth factor culture fluid, externally used drug for curing diabetes trauma using the culture fluid and preparation of the externally used drug |
| 12/24/2008 | CN101328228A Tang oligosaccharide, preparation thereof and use in radioresistant medicaments |
| 12/24/2008 | CN101328227A Sea lettuce polysaccharide, preparation and use thereof |
| 12/24/2008 | CN101328226A Low molecular rhamnosan sulfate, preparation and use thereof |
| 12/24/2008 | CN101328225A Sulfuric acid rhamnosan, preparation and use thereof |
| 12/24/2008 | CN101328224A Fructus choerospondiatis polysaccharide metal complexe and preparation thereof |
| 12/24/2008 | CN101328223A Fructus choerospondiatis polysaccharide and preparation process thereof |
| 12/24/2008 | CN101328222A Liquorice polyose metal complexes and preparation thereof |
| 12/24/2008 | CN101328202A Bark of Melia toosendan extract and use thereof |
| 12/24/2008 | CN101328200A Antineoplastic compound, preparation and use thereof |
| 12/24/2008 | CN101328199A SiRNA inhibiting human cell cycle protein A2 expression and use thereof |
| 12/24/2008 | CN101328197A Production of glucosinolates from agricultural by-products and waste |
| 12/24/2008 | CN101328196A Process for obtaining pure monosialoganglioside GM1 for medical use |
| 12/24/2008 | CN101328186A Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |